Lexicon Pharmaceuticals (LXRX)
(Delayed Data from NSDQ)
$1.58 USD
-0.08 (-4.82%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $1.59 +0.01 (0.63%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, Lexicon Pharmaceuticals (LXRX) reported earnings of -$0.17 per share, beating the Zacks Consensus Estimate of $-0.18 per share. This reflects a positive earnings surprise of 5.56%. Look out for LXRX's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year increase of 23.81%.
Earnings History
Price & Consensus
Zacks News for LXRX
Lexicon (LXRX) Up as FDA Maintains Action Date for Zynquista
LXRX: What are Zacks experts saying now?
Zacks Private Portfolio Services